Euka AI has raised $5.0M in seed funding. The company helps top e-commerce brands drive sales on TikTok Shop, pairing them with trending creators to produce winning content, then multiplying that content through a suite of AI generation tools.
Euka AI Raises $5.0M Seed Round
Get the full Euka AI company profile
Access contacts, investors, buying signals & more
From the source
news.google.com · Sep 17, 2026Euka raises $5M seed to take its TikTok Shop playbook to Instagram - Dealroom Before you continue EN English United States Deutsch English Español Français Italiano All languages Afrikaans azərbaycan bosanski català Čeština Cymraeg Dansk Deutsch eesti English United Kingdom Español España Español Latinoamérica euskara Filipino Français Canada Français France Gaeilge galego Hrvatski Indonesia isiZulu íslenska Italiano Kiswahili latviešu lietuvių magyar Melayu Nederlands norsk o‘zbek polski Português Brasil Português Portugal română shqip Slovenčina slovenščina srpski (latinica) Suomi Svenska Tiếng Việt Türkçe Ελληνικά беларуская български кыргызча қазақ тілі македонски монгол Русский српски Українська ქართული հայերեն עברית اردو العربية فارسی አማርኛ नेपाली मराठी हिन्दी অসমীয়া বাংলা ਪੰਜਾਬੀ ગુજરાતી ଓଡ଼ିଆ தமிழ் తెలుగు ಕನ್ನಡ മലയാളം සිංහල ไทย ລາວ မြန်မာ ខ្មែរ 한국어 日本語 简体中文 繁體中文 繁體中文 香港 Sign in EN English United States Deutsch English Español Français Italiano All languages Afrikaans azərbaycan bosanski català Čeština Cymraeg Dansk Deutsch eesti English United Kingdom Español España Español Latinoamérica euskara Filipino Français Canada Français France Gaeilge galego Hrvatski Indonesia isiZulu íslenska Italiano Kiswahili latviešu lietuvių magyar Melayu Nederlands norsk o‘zbek polski Português Brasil Português Portugal română shqip Slovenčina slovenščina srpski (latinica) Suomi Svenska Tiếng Việt Türkçe Ελληνικά беларуская български кыргызча қазақ тілі македонски монгол Русский српски Українська ქართული հայերեն עברית اردو العربية فارسی አማርኛ नेपाली मराठी हिन्दी অসমীয়া বাংলা ਪੰਜਾਬੀ ગુજરાતી ଓଡ଼ିଆ தமிழ் తెలుగు ಕನ್ನಡ മലയാളം සිංහල ไทย ລາວ မြန်မာ ខ្មែរ 한국어 日本語 简体中文 繁體中文 繁體中文 香港 Sign in Before you continue to Google We use cookies and data, including IP addresses, to Deliver and maintain Google services Track outages and protect against spam, fraud, and abuse Measure audience engagement and site statistics to understand how our services are used and enhance the quality of those services If you choose to “Accept all,” we will also use cookies and data, including IP addresses, to Develop and improve new services Deliver and measure the effectiveness of ads Show personalized content, depending on your settings Show personalized ads, depending on your settings If you choose to “Reject all,” we will not use cookies or IP addresses for these additional purposes.
Other United States companies recently funded
View all
Retham Technologies
Retham Technologies™ LLC was established in 2017 to translate recent discoveries into a life-saving in vitro diagnostic (IVD) assay that provides earlier and more accurate in-hospital diagnosis of Heparin-induced Thrombocytopenia (HIT). HIT is a serious adverse reaction to the blood thinner heparin. It is characterized by a drop in platelet count (thrombocytopenia) and in ~1/3rd of cases, causes blood clotting (thrombosis) that can result in life-and-limb threatening consequences such as amputation, stroke and death. The diagnosis of HIT is challenging. A family of easy-to-run tests called PF4 ELISAs is performed in the hospital laboratory but have high false positive rates, i.e. many patients positive for antibodies to PF4:polyanion complexes do not have clinical HIT. A second test, the Serotonin release assay (SRA), is considered the “gold-standard” test for HIT; but, it is performed only at a handful of laboratories nationally on a small fraction of suspected cases due to technical complexity, cost and turnaround time concerns. Thus, >90% of HIT suspected patients are currently managed using PF4 ELISAs, and thousands of patients receive costly non-heparin anticoagulant therapy due to “false positive” diagnoses. These alternative anticoagulants have a worse bleeding risk profile relative to heparin often resulting in severe or fatal hemorrhage. Retham Technologies™ is developing HITDx™, an IVD assay for early and accurate near-patient HIT diagnosis that is expected to facilitate timely and appropriate therapy thereby leading to better outcomes.
$1.5M Seed
today
Biggest recent Ecommerce rounds
Largest funding rounds in Ecommerce on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Datarize South Korea | Series b | $15.0B | 1y ago |
| 2 |  마인이스(차란) South Korea | Series a | $10.0B |
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Norlix Denmark | Seed | $1.5M | today |
| 2 |  Enlight Metals Private Limited India | Seed | $1.5M | today |
